News2 min read
Controlant and SmartCAE to transform lane risk assessment and thermal packing selection in pharma
Controlant, a global leader in real-time supply chain monitoring, and SmartCAE, a pioneer in cold chain simulation, have announced a new partnership. The collaboration aims to transform thermal packaging solutions for the pharmaceutical industry and logistics service providers by combining Controlant’s expertise in pharma supply chains with SmartCAE’s powerful engine for thermal packaging simulation and lane risk assessment, to improve safety, efficiency, and sustainability.

On this page
Balancing patient safety, costs, and environmental footprint
Thermal packaging for temperature-sensitive drugs is a balancing act of safety, cost, and carbon emission goals. If packaging isn’t up to the task, life-saving medicines could lose their efficacy due to temperature fluctuations, creating serious consequences for patients and potential stock-outs of medicines. Overengineering, on the other hand, adds unnecessary costs and excessive carbon footprint, wasting valuable resources.
Smarter packaging selection
In partnership, Controlant and SmartCAE look to solve both sides of the equation by helping pharma companies and logistics providers make smarter and greener data-driven decisions.
By integrating Controlant’s real-time data from its IoT loggers, capturing detailed information about shipment conditions, including temperature, and location, with SmartCAE’s advanced simulations, pharmaceutical companies can make more informed decisions on packaging as well as routes and services.

Real data to drive real results
“Our collaboration with SmartCAE is another step forward in our mission to transform pharma supply chains, combining our extensive pharma and technological expertise,” said Gísli Herjólfsson, CEO and co-founder at Controlant. “With this partnership and by leveraging real-time data from our IoT loggers, we enable our customers to lower costs, protect patients, and reduce waste by making data-driven decisions on optimal thermal packaging. Ultimately, this propels us forward on our ambition towards zero-waste pharma supply chains.”
“SmartCAE sees collaboration between different stakeholders in the industry as key to making cold chains safer, greener, and more cost efficient,” says Stefan Braun, Managing Director and founder of SmartCAE. Our Digital Twin technology and real-time IoT loggers provide more insights to drive faster, data-driven decisions about the right packaging for a given lane.”
Pioneering the future of cold chain management
This integrated approach enables continuous evaluation of the costs, risks, and environmental impacts of thermal packaging and logistics. Customers can then adjust their packaging strategies to seasonal variations and real-world conditions when managing temperature-sensitive products across a complex distribution network, ensuring safe and effective delivery of pharmaceutical products.
The collaboration will be highlighted at the upcoming HPCLC Fall 2024 conference, 14‑16 October, where Roche, Controlant, and SmartCAE will showcase their joint efforts to revolutionize cold chain logistics for the pharmaceutical industry.
About SmartCAE
SmartCAE provides simulation software for cold chain logistics. Their Digital Twin platform enables companies to perform temperature simulations that assess risks associated with thermal packaging solutions. By combining real-world data with advanced modeling techniques, SmartCAE helps businesses optimize packaging strategies, reduce costs, and ensure the safe delivery of temperature-sensitive products.
More news
All news
Controlant and FDK announce strategic partnership
Controlant, a global leader in pharma supply chain monitoring and automation, is proud to announce a strategic partnership with FDK Corporation (a subsidiary of Fujitsu), renowned for its expertise in battery technology. This collaboration will see Controlant leveraging FDK’s cutting-edge Nickel Metal Hydride (NiMH) batteries in its solutions, strengthening its commitment to reliability, sustainability, and performance.
Read
Results of Controlant’s Annual General Meeting: 5 May 2025
Controlant reports 2024 results, announces new board members and roadmap toward profitability in 2025. Kópavogur, Iceland, 5 May 2025: Controlant hf., a global leader in real-time supply chain visibility solutions for the pharmaceutical industry, held its Annual General Meeting (AGM) today. All proposals of the Board of Directors to the meeting were approved. The Company’s financial results for 2024 and outlook for 2025 were presented and two new board members were elected.
Read
SpotSee and Controlant announce strategic collaboration to expand shipment visibility and last-mile proof for life sciences
SpotSee and Controlant today announced a strategic collaboration designed to help life sciences organizations expand shipment visibility, strengthen proof of condition and scale monitoring programs more efficiently across temperature-sensitive supply chains.
ReadWant to talk to someone at Controlant?
Questions about the company, our certifications, or working here: we read every message.